CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


MultiStemWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (3)


Name (Synonyms) Correlation
drug220 Control Wiki 0.50
drug900 Vitamin C Wiki 0.45
drug616 Placebo Wiki 0.10

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D018352 Coronavirus Infections NIH 0.06

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 A Phase 2/3 Study to Assess the Safety and Efficacy of MultiStem® Therapy in Subjects With Acute Respiratory Distress Syndrome (ARDS) Due to Coronavirus Disease (COVID-19)

Multicenter investigation featuring an open-label lead-in followed by a double blinded, randomized, placebo-controlled Phase 2/3 part to evaluate the safety and efficacy of MultiStem therapy in subjects with moderate to severe Acute Respiratory Distress Syndrome (ARDS) due to COVID-19.

NCT04367077 ARDS Biological: MultiStem Biological: Placebo

Primary Outcomes

Measure: Ventilator-Free Days

Time: Day 0 through Day 28.

Measure: Safety and Tolerability as measured by the incidence of treatment-emergent adverse events as assessed by CTCAE v5.0.

Time: Day 28

Secondary Outcomes

Measure: All-cause mortality

Time: Day 60

Measure: Ranked hierarchical composite outcome of alive and ventilator-free

Time: Day 28

Measure: Ventilator-free days

Time: Day 0 through Day 60


No related HPO nodes (Using clinical trials)